A Major Research Foundation in Europe

The foundation needed to assess the commercial potential of its life sciences patent portfolio and establish a structured out-licensing pipeline to maximize returns on research investments. The leadership sought an authoritative, independent strategic evaluation to optimize grant allocation mechanisms, streamline technology transfer workflows, and align regional innovation policies with global best practices.

Oxford Oracle conducted an exhaustive IP portfolio audit, identifying high-value therapeutic and diagnostic assets and formulating targeted out-licensing packages for biopharma leaders. Oxford Oracle deployed a multidisciplinary advisory team to execute comprehensive technical due diligence, design bespoke commercialisation roadmaps, and establish standardized stage-gate evaluation metrics. This comprehensive initiative significantly accelerated time-to-market for novel inventions while safeguarding core institutional IP rights and fostering regional economic growth.

The out-licensing strategy generated €5.6 million in upfront licensing fees and recurring royalties, funding 4 new institutional research laboratories. Furthermore, the engagement established a permanent, scalable operational blueprint, driving long-term strategic alignment, continuous revenue growth, and enhanced institutional reputation across global innovation networks.